Abstract Treatment with amiodarone is associated with changes in thyroid function tests, but
also with thyroid dysfunction (amiodarone-induced hypothyroidism, AIH, and amiodarone …

Amiodarone is a potent class III anti-arrhythmic drug used in clinical practice for the
prophylaxis and treatment of many cardiac rhythm disturbances, ranging from paroxismal …

Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is
recommended. The usefulness of periodic TSH measurement every 6 months during AM …

Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of
tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes …

Objective Amiodarone is used for the maintenance of sinus rhythm in patients with
arrhythmias, but thyroid dysfunction (amiodarone-induced thyrotoxicosis (AIT) or …

Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-
induced thyrotoxicosis (AIT) in 7–15% of patients. AIT is a major issue due to its typical …

Background—Amiodarone is widely used in adults with congenital heart disease, but no
systematic study has been published on its effects on thyroid function in these patients. A …

Amiodarone blocks the action of thyroid hormone by the inhibition of 5′-deiodinase which
reduces production of T 3 in peripheral tissues and possibly by blocking nuclear binding of T …

Background: Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition that is
notoriously difficult to manage; the relative risk of adverse cardiovascular events in these …

BACKGROUND: Many patients receiving amiodarone therapy are male. The long-term risk
for amiodarone-induced thyroid dysfunction in these patients has not been systematically …